908 Devices Protects Joint Forces Under DoD CBRN Program Award

MX908 is rugged and meets the requirements for use in harsh environments, and with the new Drug Hunter Mode - unlocks additional resolving power from the device’s existing hardware to dramatically upgrade selectivity providing first responders with optimal detection and identification capabilities for a subset of the devices target list, including a broad range of fentanyls, opioids, and amphetamines.
MX908 is rugged and meets the requirements for use in harsh environments, and with the new Drug Hunter Mode - unlocks additional resolving power from the device’s existing hardware to dramatically upgrade selectivity providing first responders with optimal detection and identification capabilities for a subset of the devices target list, including a broad range of fentanyls, opioids, and amphetamines.

908 Devices was recently awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.

908 Devices is widely recognized for its patented and award-winning high-pressure mass spectrometry™ (HPMS) technology, which powers its line of handheld chemical detection and identification devices.

This includes the flagship M908™ and the MX908™.

The MX908 Drug Hunter Mode unlocks additional resolving power from the device’s existing hardware to dramatically upgrade selectivity, which provides first responders with optimal detection and identification capabilities for a subset of the devices target list, including a broad range of fentanyls, opioids, and amphetamines.
The MX908 Drug Hunter Mode provides first responders with optimal detection and identification capabilities, including a broad range of fentanyls, opioids, and amphetamines.

As a recipient of the $8.2 billion, multi-vendor contract, 908 Devices has been named a qualified contractor by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), whose mission it is to protect the Joint Force from weapons of mass destruction by generating affordable capabilities.

Leveraging the power of HPMS, 908 Devices now has the opportunity to compete for JE-RDAP task orders specific to future research, development, production, and fielding of Chemical, Biological, Radiological and Nuclear (CBRN) defense systems.

“We are excited to be named a qualified contractor and for the opportunities it provides,” explained Dr. Kevin J. Knopp, President and CEO, 908 Devices.

Dr. Kevin J. Knopp, President and CEO, 908 Devices
Dr. Kevin J. Knopp, President and CEO, 908 Devices

“We believe our handheld high-pressure mass spec platform can play a critical role in the modern response mission and look forward to working closely with the military to support and enhance its CBRN response needs.”

“2017 was been an exciting year for our safety and security team, and being a recipient of the JE-RDAP contract allows us to be an innovation partner with the government,” added John Kenneweg, Vice President, 908 Devices.

“We will continue to explore and push the boundaries of our HPMS technology so as to be ready to support the evolving CBRN mission for years to come.”

908 Devices New MX908™ Software Update with Drug Hunter New Mission Mode

The Drug Hunter mode unlocks additional resolving power from the devices existing hardware to dramatically upgrade selectivity, which provides first responders with optimal detection and identification capabilities for a subset of the MX908’s target list, including a broad range of fentanyls, opioids, and amphetamines.

In addition to the Drug Hunter mode, the software update includes two new additional modes – Chemical Warfare Hunter and the Explosive Hunter – which provides enhanced performance for those missions.

Protecting First Responders and Communities from the Fentanyl Crisis

As synthetic opioids — primarily fentanyl and its analogues – continue to pose a growing threat, first responders are increasingly turning to chemical detection devices to combat the problem.

(See the MX908 in action! Courtesy of Vimeo and YouTube. Courtesy of 908 Devices)

However, currently deployed devices have their limitations, as many lack sensitivity and require high concentration bulk samples for testing along with extensive libraries to accurately detect fentanyl compounds.

Harnessing the power of 908 Devices’ patented HPMS technology, this product update enables MX908 to selectively detect and identify low-concentration street-drugs in the real world.

Dr. Christina Baxter, CEO at Emergency Response TIPS
Dr. Christina Baxter, CEO at Emergency Response TIPS

“In the past 10 years, we’ve seen a stark pivot in how fentanyl is being used,” said Dr. Christina Baxter, CEO of Emergency Response Tips, LLC and former Program Manager for the Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE) subgroup at the Technical Support Working Group (TSWG).

“What was originally developed to help cancer patients combat pain is now being mixed into drugs such as heroin and cocaine, often unbeknownst to the buyer, for a cheaper sale.”

“As this problem has grown into an epidemic, new and innovative technologies will be instrumental in protecting first responders and communities from these threats and fighting this battle head on.”

Leveraging MX908, first responders can now detect fentanyl at trace-level.

(How does the MX908 work? See how here. Courtesy of Vimeo and YouTube. Courtesy of 908 Devices)

Recent independent lab testing demonstrates that MX908 can accurately detect substances with purity levels that are as low as 1 percent concentration, whereas other devices can only be leveraged on substances with a 5-10 percent concentration.

This capability allows responders to detect a variety of fentanyl analogs, ranging from traditional fentanyl to carfentanyl, which is 10,000 times more powerful than morphine.

John Kenneweg, Vice President, 908 Devices
John Kenneweg, Vice President, 908 Devices

“Six months after launch, we are proud to introduce this update to addresses the fentanyl epidemic.”“When we first deployed MX908 last June, our goal was to continue to evolve its threat list to address the chemical dangers currently fueling community epidemics, public safety concerns, and military response,” added Kenneweg.

“The Drug Hunter mode transforms MX908 into a more sensitive and selective device, allowing us to help combat the threats that plague our communities.”

MX908 New Mission Modes

MX908 is rugged and meets the requirements for use in harsh environments.
MX908 is rugged and meets the requirements for use in harsh environments.

MX908 delivers dramatically enhanced sensitivity and broader threat category coverage.

This second-generation tool increases mission support with unmatched flexibility and detection power for elite responders in chemical, explosive, and high priority toxic industrial chemical (TIC) scenarios.

MX908 is equipped with modular accessories for ease of transition between solid and vapor sample types.
MX908 is equipped with modular accessories for ease of transition between solid and vapor sample types.


New MX908 Mission Modes enhance performance using specialized software configurations to optimize operational performance of existing hardware for mission objectives.
Designed for true trace-level detection and identification for a variety of CBRNE and HAZMAT response missions, MX908 lightens the overall technology burden by obsoleting other less selective technologies from the response mission.

Drug Hunter:

  • Drug Hunter is a mission mode for the detection of drugs and pharmaceutical-based agents (PBAs) such as, fentanyl and fentanyl-analogues, along with other high priority drugs-of-abuse.

Explosives Hunter:

  • Explosives Hunter is a mission mode for the detection of priority threats from military and commercial grade explosives, to home-made energetics and relevant precursors.

Chemical Warfare Hunter (CWA) Hunter:

  • CWA is a mission mode for the detection of priority chemical warfare agents, including real-time vapor quantification.

Next-Level HPMS For All Hazard Trace Detection and Identification

Simultaneous Detection of Multiple Targets
Simultaneous Detection of Multiple Targets

ALL HAZARD THREAT DETECTION

New MX908 Mission Modes enhance performance using specialized software configurations to optimize operational performance of existing hardware for specific mission objectives.

This second-generation tool increases mission support with unmatched flexibility and trace detection power for elite responders in chemical, explosive, drug and priority hazmat scenarios.

MX908™ leverages HPMS to deliver dramatically enhanced sensitivity and broader threat category coverage.

MX908 lightens the overall technology burden by displacing other less selective technologies from the response toolkit.

LIGHTENING THE LOAD

With the enhanced proficiency of HPMS, users can lighten the technology load of tools required downrange.

With sensitivity levels comparable to ion mobility mass spectrometry (IMS) and significantly enhanced selectivity, MX908 can detect trace quantities (low – mid ppb) of priority threats amongst the myriad of interferents that plague other less selective technologies.

MX908 SPECIFICATIONS

To learn more about these new Mission Modes and see MX908 in action visit 908devices.com/fentanyl.